At a glance
ClinicalIndex Comparison RecordN/ACompleted· 57 enrolled
Drug / intervention
Fractyl Duodenal Remodeling Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Fractyl Duodenal Remodeling System for the Treatment of Type 2 Diabetes
In Brief
A clinical study evaluating Fractyl Duodenal Remodeling System for Type II Diabetes. Completed, enrolled 57 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the safety and feasibility of the Fractyl Duodenal Remodeling System for the treatment of patients with poorly controlled Type 2 Diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType II Diabetes
CountriesChile
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJul 2013
First PostedAug 2013
Primary CompletionApr 2017
Study CompletionMar 2018
TodayJul 2026
First PostedAug 22, 2013
Enrollment StartJul 13, 2013
Primary CompletionApr 7, 2017
Study CompletionMar 16, 2018
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 12.9 years ago
Interventions
Fractyl Duodenal Remodeling Systemdevice